HRSA-25-005: Fiscal Year (FY) 2025 Quality Improvement Fund – Transitions in Care for Justice-Involved Populations (QIF-TJI)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2024.
Health Resources and Services Administration offered grants of up to $1.0 million to the applicants described in the notice. It expected to make about 51 awards worth $51.0 million in total. Applications closed on June 10, 2024.
From the official notice on Grants.gov, last changed April 10, 2024. Checked November 7, 2026.
- Award ceiling$1.0 million
- Total funding$51.0 million
- Expected awards51
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | April 10, 2024 |
|---|---|
| Deadline | June 10, 2024 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Your organization must be a Health Center Program award recipient with an active H80 grant award to apply. Health Center Program award recipients are organizations funded under Section 330(e), (g), (h), and/or (i) of the Public Health Service Act.
Is this a realistic fit?
- Past Grants for New and Expanded Services under the Health Center Program awards averaged $2.8 million; this notice allows up to $1.0 million per award.
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity for health centers funded by HRSA under section 330 of the Public Health Service Act to apply for funding under Fiscal Year (FY) 2025 Quality Improvement Fund – Transitions in Care for Justice-Involved Populations (QIF-TJI). The purpose of this funding opportunity is to strengthen transitions in care for individuals who will soon be released from incarceration, increasing their access to community-based, high-quality primary care services. Through this one-time investment, health centers will build upon existing evidence-based models to pilot innovative approaches that connect or reconnect justice-involved individuals reentering the community (JI-R) to in-scope health center services that address critical health and health-related social needs. FY 2025 QIF-TJI award recipients will pilot models of care that increase access to and engagement with health center services for JI-R individuals as they prepare for release from incarceration and return to living in the community. Your proposed QIF-TJI activities must align with the Health Center Program Scope of Project Policy Manual (Scope Policy Manual). A list of in-scope services for JI-R individuals is included in Appendix C. Carceral authorities are obligated to provide medical care to incarcerated individuals within the carceral setting. Health centers may not use QIF-TJI funding to replace the obligations of carceral authorities to provide medical care or for any activities that are not specifically focused on engaging JI-R individuals with health center community-based primary health care to support transitions in care. In addition, health centers cannot use QIF-TJI funding to provide medical care to individuals who are more than 90 days from scheduled or expected release from incarceration or activities that are not aligned with associated guidance in this NOFO and its appendices. For more details, see Program Requirements and Recommendations.
Who has won Grants for New and Expanded Services under the Health Center Program grants before
From fiscal 2021 to 2025, Grants for New and Expanded Services under the Health Center Program (93.527) awarded $12 billion across 4,298 grant awards, an average of $2.8 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Clinica Sierra Vista | California | 3 | $57.7 million |
| Sun River Health, Inc. | New York | 4 | $56.5 million |
| Yakima Valley Farm Workers Clinic | Washington | 3 | $48.6 million |
| Quality of Life Health Services, Inc. | Alabama | 3 | $40.4 million |
| Family Healthcare Network | California | 2 | $39.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-25-005 still open?
No. It closed on June 10, 2024.
Who can apply for Fiscal Year (FY) 2025 Quality Improvement Fund – Transitions in Care for Justice-Involved Populations (QIF-TJI)?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Fiscal Year (FY) 2025 Quality Improvement Fund – Transitions in Care for Justice-Involved Populations (QIF-TJI)?
Closed June 10, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.0 million each. About $51.0 million in total across about 51 awards.
Who has won Grants for New and Expanded Services under the Health Center Program grants before?
The largest recipients over five fiscal years were Clinica Sierra Vista, Sun River Health, Inc., Yakima Valley Farm Workers Clinic. The program made 4,298 awards worth $12 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)